Literature DB >> 31097148

Free-access copy-number variant detection tools for targeted next-generation sequencing data.

Iria Roca1, Lorena González-Castro2, Helena Fernández2, Mª Luz Couce3, Ana Fernández-Marmiesse4.   

Abstract

Copy number variants (CNVs) are intermediate-scale structural variants containing copy number changes involving DNA fragments of between 1 kb and 5 Mb. Although known to account for a significant proportion of the genetic burden in human disease, the role of CNVs (especially small CNVs) is often underestimated, as they are undetectable by traditional Sanger sequencing. Since the development of next-generation sequencing (NGS) technologies, several research groups have compared depth of coverage (DoC) patterns between samples, an approach that may facilitate effective CNV detection. Most CNV detection tools based on DoC comparisons are designed to work with whole-genome sequencing (WGS) or whole-exome sequencing (WES) data. However, few methods developed to date are designed for custom/commercial targeted NGS (tg-NGS) panels, the assays most commonly used for diagnostic purposes. Moreover, the development and evaluation of these tools is hindered by (i) the scarcity of thoroughly annotated data containing CNVs and (ii) a dearth of simulation tools for WES and tg-NGS that mimic the errors and biases encountered in these data. Here, we review DoC-based CNV detection methods described in the current literature, assess their performance with simulated tg-NGS data, and discuss their strengths and weaknesses when integrated into the daily laboratory workflow. Our findings suggest that the best methods for CNV detection in tg-NGS panels are DECoN, ExomeDepth, and ExomeCNV. Regardless of the method used, there is a need to make these programs more user-friendly to enable their use by diagnostic laboratory staff who lack bioinformatics training.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CNV-detection tools; Gene panels; Simulated data; Targeted next-generation sequencing

Mesh:

Year:  2019        PMID: 31097148     DOI: 10.1016/j.mrrev.2019.02.005

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN: 1383-5742            Impact factor:   5.657


  14 in total

1.  An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.

Authors:  Serena Corsini; Elena Pedrini; Claudio Patavino; Maria Gnoli; Marcella Lanza; Luca Sangiorgi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

2.  Copy Number Variation Detection Using Total Variation.

Authors:  Fatima Zare; Sheida Nabavi
Journal:  ACM BCB       Date:  2019-09

3.  Detection of copy-number variations from NGS data using read depth information: a diagnostic performance evaluation.

Authors:  Olivier Quenez; Kevin Cassinari; Sophie Coutant; François Lecoquierre; Kilan Le Guennec; Stéphane Rousseau; Anne-Claire Richard; Stéphanie Vasseur; Emilie Bouvignies; Jacqueline Bou; Gwendoline Lienard; Sandrine Manase; Steeve Fourneaux; Nathalie Drouot; Virginie Nguyen-Viet; Myriam Vezain; Pascal Chambon; Géraldine Joly-Helas; Nathalie Le Meur; Mathieu Castelain; Anne Boland; Jean-François Deleuze; Isabelle Tournier; Françoise Charbonnier; Edwige Kasper; Gaëlle Bougeard; Thierry Frebourg; Pascale Saugier-Veber; Stéphanie Baert-Desurmont; Dominique Campion; Anne Rovelet-Lecrux; Gaël Nicolas
Journal:  Eur J Hum Genet       Date:  2020-06-26       Impact factor: 4.246

4.  EMQN best practice guidelines for genetic testing in dystrophinopathies.

Authors:  Carl Fratter; Raymond Dalgleish; Stephanie K Allen; Rosário Santos; Stephen Abbs; Sylvie Tuffery-Giraud; Alessandra Ferlini
Journal:  Eur J Hum Genet       Date:  2020-05-18       Impact factor: 4.246

5.  Estimating Copy-Number Proportions: The Comeback of Sanger Sequencing.

Authors:  Eyal Seroussi
Journal:  Genes (Basel)       Date:  2021-02-17       Impact factor: 4.096

6.  Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer.

Authors:  Louisa Lepkes; Mohamad Kayali; Britta Blümcke; Jonas Weber; Malwina Suszynska; Sandra Schmidt; Julika Borde; Katarzyna Klonowska; Barbara Wappenschmidt; Jan Hauke; Piotr Kozlowski; Rita K Schmutzler; Eric Hahnen; Corinna Ernst
Journal:  Cancers (Basel)       Date:  2021-01-01       Impact factor: 6.639

Review 7.  Progress in Methods for Copy Number Variation Profiling.

Authors:  Veronika Gordeeva; Elena Sharova; Georgij Arapidi
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

8.  Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders.

Authors:  Ferhat Guzel; Micol Romano; Erdi Keles; David Piskin; Seza Ozen; Hakan Poyrazoglu; Ozgur Kasapcopur; Erkan Demirkaya
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

Review 9.  Is Gene-Size an Issue for the Diagnosis of Skeletal Muscle Disorders?

Authors:  Marco Savarese; Salla Välipakka; Mridul Johari; Peter Hackman; Bjarne Udd
Journal:  J Neuromuscul Dis       Date:  2020

10.  Genomic Signature of Oral Squamous Cell Carcinomas from Non-Smoking Non-Drinking Patients.

Authors:  Kendrick Koo; Dmitri Mouradov; Christopher M Angel; Tim A Iseli; David Wiesenfeld; Michael J McCullough; Antony W Burgess; Oliver M Sieber
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.